Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2022-09-28 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Closure of trading window
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or announcement text. Given the lack of any meaningful information, this document does not represent a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2022-09-28 English
General updates
Capital/Financing Update Classification · 95% confidence The document is an official letter addressed to stock exchanges (BSE and NSE) regarding the incorporation of a wholly owned subsidiary company. It references compliance with SEBI Listing Regulations and provides detailed information about the subsidiary, including share capital, directors, and business purpose. The document is an announcement of a corporate action (incorporation of a subsidiary) rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. The document length is 4348 characters, which is relatively short and consistent with an announcement. Therefore, the document fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through the creation of a subsidiary.
2022-09-07 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding scheduled interactions with investors and analysts. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about events or information that may affect the price of securities. The document does not contain any financial data, report content, or detailed analysis. It is an announcement about an upcoming investor conference and meetings, not a financial report or earnings release. The length is only 1773 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-06 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges and the Board of Directors regarding the resignation of an Executive Director, Mrs. Sujata S Shetty. It includes details about the resignation, confirmation of no other material reasons, and requests for formalities to be completed. The content focuses on management changes rather than financial results, audit information, or regulatory filings. There is no indication of financial data, report publication, or voting results. The document fits the category of announcements related to changes in the company's board or senior management.
2022-08-25 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces scheduled interactions with investors and analysts, specifying dates and firms involved. There is no financial data, report content, or detailed analysis present. The document is essentially an announcement of investor meetings, not a financial report or detailed presentation. The length is only 1518 characters, which is quite short and fits the profile of a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-18 English
Newspaper Advertisements
Regulatory Filings
2022-08-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.